The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Hoth Therapeutics has submitted for ethics approval in Australia for its planned Clinical study of its therapeutic BioLexa for Atopic Dermatitis.
read more
AstraZeneca has concluded an agreement with the European Commission (EC) to supply up to 400 million doses of the AZD1222 COVID-19 vaccine.
read more
Akeso announced the FDA has granted Fast Track Designation for AK104 for the treatment of patients with recurrent or metastatic squamous cervical ...
read more
Moderna announced that the U.S. government has secured 100 million doses of mRNA-1273.
read more
The FDA notified IGC it has authorized the initiation Phase 1 human trial study for the Company’s investigational cannabinoid formulation for the ...
read more
Thursday, August 20, 2020
United Therapeutics announced the FDA accepted for review the sNDA for Tyvaso Inhalation Solution for the treatment of pulmonary hypertension ...
read more
A preclinical study testing the generic drug nafamostat in human cells shows it can help block SARS-CoV-2 infection.
read more
The FDA is alerting patients and health care professionals to Bayshore's voluntary recall of two lots of ER metformin.
read more
ReiThera has announced the first healthy volunteer has been dosed in a Phase 1 study of the Company's vaccine candidate (GRAd-COV2) against the novel ...
read more
The FDA approved Lampit for Chagas disease, caused by Trypanosoma cruzi, in pediatric patients
read more
Catalent announced the company will provide drug substance manufacturing to AstraZeneca for the University of Oxford’s adenovirus vector-based COVID-...
read more
AbbVie submitted an application for a new indication to the FDA for Rinvoq, a selective and reversible JAK inhibitor, for the treatment of adult ...
read more
Wednesday, August 26, 2020
The FDA is providing a laboratory testing method to assess the quality of finished hand sanitizer products.
read more
Wednesday, August 26, 2020
Oncolytics Biotech announced the first patient has been dosed in the phase 2 study of pelareorep-anti-PD-1 combination therapy in triple-negative ...
read more
Wednesday, August 26, 2020
Chemomab announces the EC has granted ODD to its lead drug candidate CM-101 for the treatment of patients with Primary Sclerosing Cholangitis.
read more